Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | EDNRA | P25101 | 3/20 | 0.43 |
| ▸ | EDNRB | P24530 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | MAOB | P27338 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | BLM | P54132 | 1/20 | 0.41 |
| ▸ | CBS | P35520 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11212671 | 0.85 | GABRA1 (0.44) | GABRA1GABRB2CYP3A4MAPK1EDNRA | |
| SCHEMBL6864759 | 0.82 | CYP2C19 (0.49) | CYP3A4MAPK1MAPTNPC1RAB9A | |
| SCHEMBL170331 | 0.82 | MAOA (0.41) | EDNRAMAPTMAOBMEN1KMT2A | |
| SCHEMBL30775734 | 0.82 | MAOA (0.41) | EDNRAMAPTMAOBMEN1KMT2A | |
| SCHEMBL1257771 | 0.82 | MAOA (0.41) | EDNRAMAPTMAOBMEN1KMT2A | |
| SCHEMBL11342705 | 0.81 | EDNRA (0.42) | GABRA1GABRB2CYP3A4MAPK1EDNRA | |
| SCHEMBL29066395 | 0.78 | CYP3A4 (0.40) | CYP3A4MAPK1EDNRAEDNRBMAPT | |
| SCHEMBL10367170 | 0.75 | MAOB (0.48) | CYP3A4MAPTNPC1RAB9AMAOB | |
| SCHEMBL10694325 | 0.74 | EDNRA (0.49) | GABRA1GABRB2EDNRAEDNRBMAPT | |
| SCHEMBL10694317 | 0.74 | EDNRA (0.49) | GABRA1GABRB2EDNRAEDNRBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113136026-A | Forming method of sealed shell for photoelectric sensor | 杭州安誉科技有限公司 | 2021-07-20 | — | — | CN | claimed |
| CN-112423600-A | Taste modifier composition, beverage and flavouring composition thereof | 阿尔门德拉私人有限公司 | 2021-02-26 | — | — | CN | claimed |
| CN-116637102-B | Application of flavane compound in preparation of antitumor drugs | 北京中医药大学 | 2024-04-09 | — | — | CN | disclosed |
| CN-116637102-A | Application of flavane compound in preparation of antitumor drugs | 北京中医药大学 | 2023-08-25 | — | — | CN | disclosed |
| CN-113509459-B | Application of flavane compound in preparation of antitumor drugs | 北京中医药大学 | 2023-07-28 | — | — | CN | disclosed |
| CN-113509459-A | Application of flavane compound in preparing anti-tumor medicine | 北京中医药大学 | 2021-10-19 | — | — | CN | disclosed |
| CN-113136026-A | Forming method of sealed shell for photoelectric sensor | 杭州安誉科技有限公司 | 2021-07-20 | — | — | CN | disclosed |
| CN-112423600-A | Taste modifier composition, beverage and flavouring composition thereof | 阿尔门德拉私人有限公司 | 2021-02-26 | — | — | CN | disclosed |
| EP-2253226-B1 | Use of hydroxyflavone derivatives for modifying taste | LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) | 2015-07-15 | — | — | EP | disclosed |
| EP-2253226-A1 | Use of hydroxyflavone derivatives for modifying taste | Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) | 2010-11-24 | — | — | EP | disclosed |
| US-20100292175-A1 | USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION | Leibniz-Institut fur Pflanzenbiochemie (DE) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292175-A1 | USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION | TAS2R50, TAS2R60, TAS2R30 | GABRA1 1590/4885GABRB2 686/4885CYP3A4 1777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.